Precision生物科学 DTIL 深 沪
等待开盘 03-28 09:30:00 美东时间
5.865
-0.675
-10.32%
华盛通- 最 高7.59
- 今 开6.51
- 成交量 33.87万股
- 最 低 4.22
- 昨 收 6.54
- 总市值 36.47万
- 52周最高 8.8169
- 市盈率 静 --
- 换手率 544.75%
- 52周最低 3.53
- 委 比 -55.06%
- 总股本 6.22万
- 历史最高 23.67
- 量 比 0
- 振 幅 51.53%
- 历史最低 0.275
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Precision BioSciences Lands $7.5M Milestone Payment From TG Therapeutics In MS Drug Trial
Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today
03-02 20:12
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
Precision BioSciences Secures $13M From Imugene Convertible Note Maturity As Part of Azer-cel Deal
Precision BioSciences Secures $13M From Imugene Convertible Note Maturity As Part of Azer-cel Deal
2024-09-03 19:27
HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target
HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60 price target.
2024-08-23 00:19
